The University of Chicago Header Logo

Caner Saygin

Concepts (271)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Caner Saygin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Caner Saygin has written about over time.
Behcet Syndrome, 3 publications between 2013 and 2015, average publication date September 2014. Cell Self Renewal, 4 publications between 2016 and 2019, average publication date January 2018. Prognosis, 16 publications between 2013 and 2025, average publication date May 2018. Cyclophosphamide, 4 publications between 2013 and 2023, average publication date September 2018. Neoplastic Stem Cells, 9 publications between 2016 and 2024, average publication date December 2018. Clonal Evolution, 3 publications between 2017 and 2021, average publication date October 2019. Cisplatin, 4 publications between 2016 and 2024, average publication date December 2019. Antineoplastic Agents, 10 publications between 2016 and 2024, average publication date December 2019. Antineoplastic Combined Chemotherapy Protocols, 6 publications between 2014 and 2024, average publication date April 2020. Neoplasm, Residual, 3 publications between 2017 and 2022, average publication date April 2020. Neoplasms, Second Primary, 2 publications between 2019 and 2021, average publication date August 2020. Drug Resistance, Neoplasm, 6 publications between 2017 and 2024, average publication date February 2021. Leukemia, Myeloid, Acute, 7 publications between 2017 and 2025, average publication date February 2021. Myelodysplastic Syndromes, 5 publications between 2020 and 2023, average publication date June 2021. Hematopoietic Stem Cell Transplantation, 4 publications between 2017 and 2025, average publication date October 2021. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 12 publications between 2014 and 2025, average publication date March 2022. Mutation, 15 publications between 2017 and 2025, average publication date September 2022. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 3 publications between 2022 and 2023, average publication date July 2023. Tumor Suppressor Protein p53, 4 publications between 2024 and 2025, average publication date March 2025.

To see the data from this visualization as text, click here.
Saygin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (271)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_